Review article: rifabutin in the treatment of refractory Helicobacter pylori infection
出版年份 2011 全文链接
标题
Review article: rifabutin in the treatment of refractory Helicobacter pylori infection
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 35, Issue 2, Pages 209-221
出版商
Wiley
发表日期
2011-12-02
DOI
10.1111/j.1365-2036.2011.04937.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rescue Therapy Using a Rifabutin-Based Regimen is Effective for Cure ofHelicobacter pyloriInfection
- (2016) Sander Veldhuyzen van Zanten et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- High Helicobacter pylori Resistance to Metronidazole but Zero or Low Resistance to Clarithromycin, Levofloxacin, and Other Antibiotics in Malaysia
- (2011) Khean-Lee Goh et al. HELICOBACTER
- Is Culture Necessary before First-line Treatment for Helicobacter pylori Infection?
- (2011) Javier P. Gisbert INTERNAL MEDICINE
- One-Week Once-Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin
- (2010) Stephan Miehlke et al. HELICOBACTER
- Treatment of Helicobacter pylori Infection 2010
- (2010) Anthony O’Connor et al. HELICOBACTER
- Helicobacter pyloriInfection
- (2010) Kenneth E.L. McColl NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori
- (2010) M. Castro-Fernández et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis
- (2010) Yuqin Li et al. WIENER KLINISCHE WOCHENSCHRIFT
- Past Rifampicin Dosing Determines Rifabutin Resistance of Helicobacter pylori
- (2009) Shoji Suzuki et al. DIGESTION
- Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment
- (2009) F. Sacco et al. DIGESTIVE AND LIVER DISEASE
- Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK
- (2009) S. A. Chisholm et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Cumulative H. pylori Eradication Rates in Clinical Practice by Adopting First and Second-Line Regimens Proposed by the Maastricht III Consensus and a Third-Line Empirical Regimen
- (2008) Theodore Rokkas et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Emerging Therapies for the Treatment of Helicobacter pylori Infections
- (2008) Tomasz Z Jodlowski et al. ANNALS OF PHARMACOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started